Submission of intimation of allotment of equity shares in conversion of warrants.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals (formerly Trimurthi Limited) has allotted 16,61,000 equity shares at Rs. 20 each (face value Rs. 10 + premium of Rs. 10) upon conversion of an equal number of warrants. The company received Rs. 2.49 crores as the remaining 75% of the issue price from warrant holders. These warrants were originally issued on a preferential basis on 10th January 2025, out of a total of 1,50,00,000 warrants allotted at that time. There are 19 allottees in total, including promoter group entities and non-promoter investors, with Srinidhi Fine-Chemicals LLP (promoter group) receiving the largest share at 10,00,000 shares. As a result, the company's paid-up equity capital increased from Rs. 14.48 crores to Rs. 16.14 crores, with total shares rising from 1,44,80,000 to 1,61,41,000.
This is a dilution event for existing shareholders as more shares enter the market, but it also brings in additional capital and signals that warrant holders have confidence in the company to exercise their conversion option.